Atlas5D enables a new way to gather real-world information towards patient care and medical research. Many therapeutic areas, such as nervous system, cardiovascular, and bone and joint, lack technology to measure progression at home — especially over long durations of time. Echo5D by Atlas5D solves this problem by precisely measuring patient ambulation and dexterity at-home, without using wearables, requiring recharging, or invading privacy.
Zeb Kimmel, MD, MBA
Chief Executive Officer
Zeb has two decades of experience in medicine and computer science. He most recently spent five years in McKinsey’s Healthcare Technology Practice, serving governments, hospitals, pharmaceutical firms, and medical device manufacturers worldwide. Prior to McKinsey, Zeb was a postdoctoral fellow at Harvard Medical School, and an early member of the federal Office of the National Coordinator for Health Information Technology. Zeb has an MD from Northwestern University, an MBA from MIT Sloan, an MS in computer science from the University of Illinois at Urbana-Champaign, and a BA in math-physics from Brown University.
Jon Varsanik, PhD
Chief Technology Officer
Jon is an expert in image processing, data analytics, and algorithm development. Before Atlas5D, he was a technical consultant with Exponent, where he worked with some of the largest and most innovative companies in the world. He has solved problems ranging from development of consumer electronics products to creating novel threat detection algorithms to root cause analysis of industrial fires. Previously, Jon worked at Draper Laboratory as a Draper Fellow, and his thesis work was partially funded by DARPA. His scientific publications and patents include advances in nanofluidics, team dynamics, and image processing. Jon has four degrees from MIT: two bachelor’s degrees, one Masters of Engineering, and the PhD in Electrical Engineering and Computer Science.
Tim Chevalier, PhD
Chief Science Officer
Tim applies his formal training in electromagnetics and plasma physics to innovations in signal processing, computer vision, and machine learning. Before Atlas5D, he spent six years at Exponent, where his areas of expertise included ground-penetrating radar, power transmission and electromagnetic compatibility. He was one of 24 Americans to receive the Young Scientist Award from the International Union of Radio Science in 2008, and he holds a patent entitled: “Techniques for Determining Physical Properties of Underground Structures Using Lightning.” His doctoral thesis examined antenna-plasma interactions aboard near-Earth spacecraft. Tim received the PhD in Electrical Engineering from Stanford, and Bachelor’s and Master’s degrees in EE from the University of New Hampshire.
Rachel is a back-end engineer with experience in big data and data mining. Prior to joining Atlas5D she worked at SmugMug in natural language analytics and data warehousing, and at EnerNOC in energy intelligence software. Rachel holds Bachelor of Science degrees in Computer Science and Applied Statistics from the Rochester Institute of Technology.
Computer Vision Research Scientist
Katie specializes in deep-learning algorithms and applications in computer vision. Prior to joining Atlas5D, she completed software-engineering internships at Apple’s Interactive Media Group and Google’s Android Wear Division. Her undergraduate awards include MIT’s MiniPlaces Scene-Recognition Challenge in convolutional neural networks. Katie holds a Bachelor of Science degree in Computer Science and Engineering from MIT.
Computer Vision Research Scientist
Hansa began applying deep learning techniques to computer vision as an undergraduate researcher at MIT’s Computer Science and Artificial Intelligence Laboratory. Following a Google internship her sophomore year, she was awarded MIT’s MiniPlaces Scene-Recognition Challenge with Atlas5D colleague Katie Bartel. Hansa holds a Bachelor of Science degree in Computer Science and Engineering from MIT.
Emily is a full-stack engineer specializing in digital health, and co-founder of a Silicon Valley med-education startup. At IBM Watson Health, she led solutions in diabetes management for one of America’s largest healthcare providers. Emily holds a Bachelor’s degree in Political Science from Brown University.
Tyson has an extensive background in the visual arts including graphic and user interface design, illustration, and filmmaking. He has over 15 years of illustration and design experience with companies such as HP, Dell, Coke, HBO, Time Magazine, Wall Street Journal, Nike, Disney, Scholastic, Pearson, Washington Post, and MacWorld Magazine. The majority of his career has been working for non-profits in the education market. He has produced,directed and edited two feature films and a documentary. Tyson has a BA in Graphic Design from Portland State University, where he won the prestigious PRINT magazine’s Student Design Competition.
Julia Gaebler, PhD
Julia is a Partner at Health Advances, and held former leadership positions at Biogen (Senior Director, Global Market Access and Medical Outcomes Strategy), Amylin, Roche, and RAND. Trained in mathematics and health policy, she has authored publications in health technology assessment for journals such as Nature, Health Services Research, Diabetes Medicine, and Plos Medicine. More information about Julia may be found at www.healthadvances.com/leadership.
Scott Gazelle, MD, MPH, PhD
Scott is a founder of GreyBird Ventures; a Professor of Radiology at Harvard Medical School; Professor in the Department of Health Policy and Management at the Harvard School of Public Health; and Founder and Director Emeritus of the MGH Institute for Technology Assessment. He has authored more than 250 scientific articles, published 3 textbooks and presented numerous papers, lectures, and workshops nationally and internationally. More information about Scott may be found at www.greybirdventures.com.
Thomas J. Miller
Tom is a founder of GreyBird Ventures, and the former CEO of the Customer Solutions Division of Siemens Medical, where he was the first non-German CEO of a German factory and business unit. He is widely sought for speaking and advisory roles, including a recent commencement address at the prestigious Indian Institute of Technology. More information about Tom may be found at www.greybirdventures.com.
Zeb Kimmel, MD
Please see bio above.
Jon Varsanik, PhD
Please see bio above.
Bob is the VP and GM of electronics manufacturer Scanning Devices. Bob was a two-term Board President of Ethos, a non-profit that serves older and disabled residents of Boston. From 1988 to 2009, he held executive roles at Lifeline Systems, the leader in Personal Response Services: from VP of Marketing, VP Government Services, and VP and GM for Lifeline’s Consumer Service Division, to (following the 2006 acquisition by Philips) VP of Acquisitions/Integration.
Mark E. Frisse, MD
Mark is the Accenture Professor of Biomedical Informatics at Vanderbilt University and the former Chief Medical Officer of Express Scripts. He has been active in regional efforts in secure health data exchange, and led the Owen School of Management’s Masters of Management in Health Care program. Mark trained as a physician-scientist and manager at Washington University and Stanford, and is a member of the Institute of Medicine of the National Academies.
Regina E. Herzlinger
Regi is the Nancy R. McPherson Professor of Business Administration at the Harvard Business School, and author of the best-selling book “Who Killed Health Care?: America’s $2 Trillion Medical Problem – and the Consumer-Driven Cure”. She is a leader in the emerging space of online entrepreneurial education, including channel www.vimeo.com/rherzlinger and her HBS course at www.edx.org.
Tony is a globally-sought consultant in international marketing. He is the former head of Worldwide Markets for Apple; VP Marketing at AOL and at TiVo; and founder of startup Planstorm. At Apple, he was invited to testify before Congress on US education policy. More information about Tony may be found at tonylee.com.
Sam is the CEO of Vital Matters. Previously Sam was a Director (senior partner) at McKinsey and Company where he led the business technology practice covering pharmaceutical and medical products. He also co-led McKinsey’s Advanced Data and Analytics practice. Sam coined the term “real world evidence” (RWE) to describe methods for understanding the effectiveness of treatments in real-world settings.
Ronald T. Piervincenzi, PhD
Ron is the Chief Executive Officer of U.S. Pharmacopeial Convention (USP). Previously, he was a partner in McKinsey and Company’s pharmaceutical practice, where he led McKinsey’s global drug safety and regulatory service line. At Biogen Idec, he launched the Value Based Medicine division, which focuses on personalized medicine in motor disorders.
Steve leads the clinical and health management business of a large professional services company. Previously he was a partner at McKinsey and Company serving life sciences and healthcare companies. Prior, Steve was the lead analyst at Goldman Sachs covering health IT and health services companies, and the co-founder of a clinical software company whose solutions are now used by over 1,000 US hospitals. He has held Board and advisory roles with numerous health IT companies.